NCT02112929View on ClinicalTrials.gov

Regional Lung Imaging Using Hyperpolarized Xenon Gas

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Lung Disease
Interventions
DRUG

Hyperpolarized xenon

Inhalation of up to one litre of polarized xenon gas, up to four inhalations per day are permitted.

Trial Locations (1)

OX3 7LE

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors
collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

collaborator

University of Sheffield

OTHER

lead

Oxford University Hospitals NHS Trust

OTHER

NCT02112929 - Regional Lung Imaging Using Hyperpolarized Xenon Gas | Biotech Hunter | Biotech Hunter